OGT will be attending the Association for Molecular Pathology (AMP) 2022 Annual Meeting & Expo, taking place November 1-5, 2022 in Phoenix, Arizona.
AMP is the leading organization in the field of molecular diagnostics, and its annual meeting is widely considered the “premier gathering” of molecular professionals. Attendees will explore how cutting-edge technology and developments in molecular testing and diagnostics continue to have a major impact on patient care.
The AMP 2022 Program Committee is planning an impressive program to spark dialogue and engagement amongst attendees and exhibitors from around the world. Go here to view the Scientific Program as it develops.
OGT will be sponsoring a 50-minute Corporate Workshop featuring two prominent industry professionals:
We evaluated the ability of three technologies to detect partial tandem duplications in the KMT2A gene: 1) OGT’s RUO Next Generation Sequencing panel with KMT2A specific probes 2) an MLPA assay covering exons 4 and 36 of KMT2A and 3) Optical Genome Mapping
José-Mario Capo-Chichi PhD, FCCMG, FACMG, Clinical Molecular Geneticist/Staff Scientist, Department of Clinical Laboratory Genetics, Genome Diagnostics, Laboratory Medicine Program, University Health Network
Mutation profiles in AML/MDS patients from a large Southern Ontario cohort will be examined. Comparison of observed mutation frequencies to those in the literature highlight the utility of this measurement as an important quality control marker. Exceptional cases further emphasize the complexity of myeloid neoplasia biology and leukomeogenic processes.
Elizabeth McCready PhD, FCCMG, Associate Professor, McMaster University, Head of Molecular Cytogenetics, Hamilton Regional Laboratory Medicine Program, Hamilton Health Sciences